NEW YORK (GenomeWeb) – Investment bank Cowen today initiated coverage of NanoString Technologies.

In a research note, analyst Doug Schenkel gave shares of NanoString an Outperform rating with a price target of $20 per share.

"We view the risk/reward as compelling given the track record, predictable growth model, and upside sources," he said.  Over the next two to five years, NanoString can generate sales growth "exceeding most other companies in the group, and the growth outlook is relatively predictable given the company's razor/blade model," Schenkel said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.